Invention Grant
- Patent Title: Compounds
- Patent Title (中): 化合物
-
Application No.: US11747337Application Date: 2007-05-11
-
Publication No.: US08623887B2Publication Date: 2014-01-07
- Inventor: Stephan Karl Zahn , Bojan Bister , Guido Boehmelt , Ulrich Guertler , Andreas Mantoulidis , Ulrich Reiser , Andreas Schoop , Flavio Solca , Ulrike Tontsch-Grunt , Matthias Treu
- Applicant: Stephan Karl Zahn , Bojan Bister , Guido Boehmelt , Ulrich Guertler , Andreas Mantoulidis , Ulrich Reiser , Andreas Schoop , Flavio Solca , Ulrike Tontsch-Grunt , Matthias Treu
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Mary-Ellen M. Devlin
- Priority: EP06113967 20060515
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D239/02 ; C07D211/56 ; C07D211/98
Abstract:
The present invention encompasses compounds of general formula (1) wherein R1, R2, R4, Rg, X, m, n and p are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.
Public/Granted literature
- US20090163467A1 New compounds Public/Granted day:2009-06-25
Information query
